• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Threshold Pharmaceuticals Inc

+ Add to Watchlist


3.5200 USD 0.00000.00%

As of 20:10:00 ET on 01/23/2015.

Snapshot for Threshold Pharmaceuticals Inc (THLD)

Open: 3.5300 Day's Range: 3.4900 - 3.5800 Volume: 436,649
Previous Close: 3.5200 52wk Range: 2.5800 - 5.5801 1-Yr Rtn: -34.75%

Stock Chart for THLD

No chart data available.
  • THLD:US 3.5200
  • 1D
  • 1M
  • 1Y
Interactive THLD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for THLD

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3901
Est. EPS (USD) (12/2014) -0.4470
Est. PEG Ratio -
Market Cap (M USD) 220.88
Shares Outstanding (M) 62.75
30 Day Average Volume 622,315
Price/Book (mrq) -
Price/Sale (ttm) 14.6786
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for THLD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for THLD

Threshold Pharmaceuticals Inc. is a biotechnology company focused on the discovery, development and commercialization of small molecule therapeutics based on Metabolic Targeting, an approach that targets fundamental differences in metabolism between normal and certain diseased cells.

Harold E Selick "Barry"Chief Executive OfficerTillman PearceChief Medical Officer
Robert L Simon "Bob"Senior VP:Regulatory AffairsJoel A FernandesVP:Finance/Controller
More Company Profile & Key Executives for THLD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil